XML 119 R103.htm IDEA: XBRL DOCUMENT v3.3.1.900
Schedule I - Condensed Financial Information of Registrant (Condensed Statements of Comprehensive Income) (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2015
[1],[2]
Sep. 30, 2015
[3],[4]
Jun. 30, 2015
[5],[6]
Mar. 31, 2015
[7],[8]
Dec. 31, 2014
[9],[10]
Sep. 30, 2014
[11],[12]
Jun. 30, 2014
[13],[14]
Mar. 31, 2014
[15]
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Condensed Financial Statements, Captions [Line Items]                      
Net income $ 37,100 $ 60,300 $ 58,400 $ 30,000 $ 4,900 $ (8,900) $ 120,900 $ 28,800 $ 185,677 $ 145,629 $ 170,126
Unrealized gains (losses) on investments available-for-sale:                      
Unrealized holding (losses) gains arising during the period                 (10,480) 59,073 (78,217)
Less: Reclassification adjustments for gains included in earnings                 (192) (2,710) (23,975)
Unrealized (losses) gains on investments available-for-sale, net                 (10,672) 56,363 (102,192)
Defined benefit pension plans:                      
Prior service cost arising during the period                 0 0 607
Net gain (loss) arising during the period                 6,416 (11,893) 7,294
Less: Amortization of prior service cost and net loss included in net periodic pension cost                 2,560 600 2,572
Defined benefit pension plans, net                 (8,976) 11,293 (10,473)
Other comprehensive (loss) income, before tax                 (1,696) 45,070 (91,719)
Income tax (benefit) expense related to components of other comprehensive income                 (306) 15,464 (31,868)
Other comprehensive (loss) income, net of tax                 (1,390) 29,606 (59,851)
Comprehensive income                 184,287 175,235 110,275
Parent Company [Member]                      
Condensed Financial Statements, Captions [Line Items]                      
Net income                 185,677 145,629 170,126
Unrealized gains (losses) on investments available-for-sale:                      
Unrealized holding (losses) gains arising during the period                 (10,480) 59,073 (78,217)
Less: Reclassification adjustments for gains included in earnings                 (192) (2,710) (23,975)
Unrealized (losses) gains on investments available-for-sale, net                 (10,672) 56,363 (102,192)
Defined benefit pension plans:                      
Prior service cost arising during the period                 0 0 607
Net gain (loss) arising during the period                 6,416 (11,893) 7,294
Less: Amortization of prior service cost and net loss included in net periodic pension cost                 2,560 600 2,572
Defined benefit pension plans, net                 (8,976) 11,293 (10,473)
Other comprehensive (loss) income, before tax                 (1,696) 45,070 (91,719)
Income tax (benefit) expense related to components of other comprehensive income                 (306) 15,464 (31,868)
Other comprehensive (loss) income, net of tax                 (1,390) 29,606 (59,851)
Comprehensive income                 $ 184,287 $ 175,235 $ 110,275
[1] Includes $22.7 million in pretax expenses primarily related to the Cognizant Transaction.
[2] Includes $58.2 million amortization of deferred costs of health insurer's fee and $21.1 million in other ACA fees.
[3] Includes $21.7 million in pretax expenses primarily related to the Cognizant Transaction.
[4] Includes $58.4 million amortization of deferred costs of health insurer's fee and $22.2 million in other ACA fees.
[5] Includes $26.4 million in pretax expenses primarily related to the Cognizant Transaction.
[6] Includes $58.5 million amortization of deferred costs of health insurer's fee and $21.5 million in other ACA fees.
[7] Includes $1.9 million pretax asset impairment and $44.3 million in pretax expenses primarily related to the Cognizant Transaction.
[8] Includes $57.8 million amortization of deferred costs of health insurer's fee and $20.8 million in other ACA fees.
[9] Includes $3.8 million pretax asset impairment primarily related to our assets held for sale in connection with the Cognizant Transaction and $68.3 million in pretax expenses primarily related to the Cognizant Transaction.
[10] Includes $35.4 million amortization of deferred costs of health insurer's fee and $25.8 million in other ACA fees.
[11] Includes $31.9 million amortization of deferred costs of health insurer's fee and $26.6 million in other ACA fees.
[12] Includes $84.7 million pretax asset impairment related to our assets held for sale in connection with the Cognizant Transaction and $21.1 million in pretax expenses primarily related to the Cognizant transaction.
[13] Includes $37.8 million amortization of deferred costs of health insurer's fee and $22.5 million in other ACA fees.
[14] Includes tax benefit of $72.6 million, net of adjustments, as a result of a loss on the stock of one of our subsidiaries.
[15] Includes $36.3 million amortization of deferred costs of health insurer's fee and $22.5 million in other ACA fees.